Challenges in preventing relapse in major depression: Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression

Journal of Affective Disorders

Volumn 77, Issue 2, 2003, Pages 97-108

  Segal, Zindel V ^a   Pearson, Jane L ^b   Thase, Michael E ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Epidemiology; Major depressive disorder; Markers of relapse vulnerability; Pharmacological and psychological treatment; Prevention of recurrence; Relapse

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NORTRIPTYLINE;

BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE MARKER; ETHNIC DIFFERENCE; ETHNIC GROUP; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MAJOR DEPRESSION; MENTAL HEALTH; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; RELAPSE; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS;

EID: 0242721347     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00112-X     Document Type: Conference Paper

References (61)

1. Agency for Health Care Policy and Research - Depression Guidelines Panel. Depression in Primary Care. Vol 1: Clinical Practice Guidelines. (AHCPR pub. No. 93-0550) Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1993a.
2. Agency for Health Care Policy and Research - Depression Guidelines Panel. Depression in Primary Care. Vol 2: Treatment of Major Depression, Clinical Practice Guidelines. (AHCPR pub. No. 93-0551) Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1993b.
3. Alnaes R., Togersen S. Personality and personality disorders predict development and relapses of major depression. Acta Psychiatr. Scand. 95:1997;336-342.
4. American Psychiatric Association Practice Guidelines. Practice Guideline for the Treatment of Patients with Major Depressive Disorder (Revision). (2000). Am. J. Psychiatry Suppl. 157.
5. Basco M.R., Rush A.J. Compliance with pharmacology in mood disorders. Psychiatr. Ann. 25:1995;269-279.
6. Blackburn I.M., Moore R.G. Controlled acute and follow up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br. J. Psychiatry. 171:1997;328-334.
7. Brady K.T., Killeen T.K., Brewerton T., Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J. Clin. Psychiatry. 61:2000;22-32.
8. Brent D.A., Birmaher B., Kolko D., Baugher M., Bridge J. Subsyndromal depression in adolescents after a brief psychotherapy trial: course and outcome. J. Affect. Disord. 63:2001;51-58.
9. Brody A., Saxena S., Stoessel P., et al. Regional metabolic effects in patients with major depression treated with either Paroxetine or interpersonal therapy. Arch. Gen. Psychiatry. 58:2001;631-640.
10. Butzlaff R.L., Hooley J.M. Expressed emotion and psychiatric relapse: a meta-analysis. Arch. Gen. Psychiatry. 55:1988;547-552.
11. Driessen M., Meier S., Hill A., Wetterling T., Lange W., Junghaus K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol. 36:2001;249-255.
12. Drevets W. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 126:2000;413-431.
13. Evans M.D., Hollon S.D., DeRubeis J., et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch. Gen. Psychiatry. 49:1992;802-808.
14. Fava G.A., Rafanelli C., Grandi, Conti S., Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch. Gen. Psychiatry. 55:1998;816-820.
15. Fleming J.E., Boyle M.H., Offord D.R. The outcome of adolescent depression in the Ontario Child Health Study follow-up. J. Am. Acad. Child Adolesc. Psychiatry. 32:1993;28-33.
16. Frank E., Kupfer D., Perel J., Cornes C., et al. Three year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry. 47:1990;1093-1099.
17. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., Rush A.J., Weissman M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch. Gen. Psychiatry. 48:1991;851-855.
18. Frank E., Kupfer D.J., Wagner E.F., McEachran A.B., Cornes C. Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression: contributing factors. Arch. Gen. Psychiatry. 48:1991;1053-1059.
19. Frank R.G., McGuire T.G., Normand S.L., Goldman H.H. The value of mental health care at the system level: the case of treating depression. Health Affairs. 18:1999;71-88.
20. Goldapple K., Segal Z., Garson C., Beilinp P., Lau M., Mayberg H. Effects of CBT on brain glucose metabolism in patients with major depression. Biol. Psychiatry. 57:2002;665.
21. Greenwald B.S., Kramer-Ginsberg E., Krishnan K.R., Hu J., Ashtari M., Wu H., Aupperle P., Patel M., Pollack S. A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. J. Am. Geriatr. Soc. 49:2001;1218-1225.
22. Hollon S.D., Shelton R., Salmon R., Lovett M. Cognitive therapy and the prevention of relapse in severely depressed. Paper presented at the Association for the Advancement of Behavior Therapy, Philadelphia:2001.
23. Ialongo N.S., Edelson G., Kellam S.G. A further look at the prognostic power of young children's reports of depressed mood and feelings. Child Dev. 72:2001;736-747.
24. Ingram R.E., Miranda J., Segal Z.V. Cognitive Vulnerability to Depression. 1998;Guilford Press, New York.
25. Jarrett R.B., Kraft D., Doyle J., Foster B.M., Eaves G.G., Silver P.C. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch. Gen. Psychiatry. 58:2001;381-388.
26. Judd L.J. The clinical course of unipolar major depressive disorders. Arch. Gen. Psychiatry. 54:1997;989-991.
27. Katon W., Rutter C., Ludman E.J., Von Korff M., Lin E., Simon G., Bush T., Walker E., Unutzer J. A randomized trial of relapse prevention of depression in primary care. Arch. Gen. Psychiatry. 58:2001;241-247.
28. Keller M.B., Lavori P.W., Lewis C.E., Klerman G.L. Predictors of relapse in major depressive disorder. J. Am. Med. Assoc. 250:1983;3299-3304.
29. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. A longitudinal twin study of personality and major depression in women. Arch. Gen. Psychiatry. 50:1993;853-862.
30. Kraemer H.C., Stice E., Kazdin A., Offord D., Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping and proxy risk factors. Am. J. Psychiatry. 158:2001;848-856.
31. Kupfer D.J., Frank E. The interaction of drug- and psychotherapy in the long-term treatment of depression. J. Affect. Disord. 62:2001;131-137.
32. Lewinsohn P.M., Rohde P., Seeley J.R., Klein D.N., Gotlib I.H. Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. Am. J. Psychiatry. 157:2000;1584-1591.
33. Lin E.H.B., Katon W., VonKorff M., Russo J., Simon G.E., Bush T., Rutter C., Walker E., Ludman E. Relapse and recurrence of depression in primary care: rate and clinical predictors. Arch. Fam. Med. 7:1998;443-449.
34. Lin E.H.B., Katon W.J., Simon G.E., Von Korff M., Bush T.M., Walker E.A., Unutzer J., Ludman E.J. Low-intensity treatment of depression in primary care: Is it problematic? Gen. Hosp. Psychiatry. 22:2000;78-83.
35. Lin E.H., Von Korff M., Katon W., Bush T., Simon G.E., Walker E., Robinson P. The role of the primary care physician in patients' adherence to antidepressant therapy. Med. Care. 1:1995;67-74.
36. Links P.S., Heselgrave R.J., Mitton J.E., Van Reekum R., Patrick J. Borderline psychopathology and recurrences of clinical disorders. J. Nerv. Ment. Dis. 183:1995;582-586.
37. Ludman E., Von Korff M., Katon W., Lin E., Simon G., Walker E., Unòtzer J., Bush T., Wahab S. The design, implementation, and acceptance of a primary care-based intervention to prevent depression relapse. Int. J. Psychiatry Med. 30:2000;229-245.
38. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry. 156:1999;675-682.
39. Mayberg H.S., Brannan S., Mahurin R.K., McGinnin S. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry. 48:2000;830-843.
40. McGee R., Williams S. A longitudinal study of depression in nine-year-old children. J. Am. Acad. Child Adolesc. Psychiatry. 27:1988;342-348.
41. Miranda, J., Duan, N., Sherbourne, C., Schoenbaum, M., Lagomansino, I., Wells, K.B., Improving care for minorities. Can Quality Improvement Interventions Improve Care and Outcomes for Depressed Minorities? Results of a Randomized, Controlled Trial (submitted).
42. Mueller T.I., Lavori P.W., Keller M.B., Swartz A., Warshaw M., Hasin D., Coryell W., Endicott J., Rice J., Akiskal H. Prognostic effect of the variable course of alcoholism on the 10-year course of depression. Am. J. Psychiatry. 151:1994;701-706.
43. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol. Med. 25:1995;1171-1180.
44. Paykel E.S., Scott J., Teasdale J.D., Johnson A., et al. Prevention of relapse in residual depression by cognitive therapy. Arch. Gen. Psychiatry. 56:1999;829-835.
45. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br. J. Psychiatry. 162:1993;175-182.
46. Reinherz H.Z., Giaconia R.M., Hauf A.M., Wasserman M.S., Paradis A.D. General and specific childhood risk factors for depression and drug disorders by early adulthood. J. Am. Acad. Child Adolesc. Psychiatry. 39:2000;223-231.
47. Reynolds III C.F., Frank E., Perel J.M., Imber S.D., Cornes C., Miller M.D., Mazumdar S., Houck P.R., Dew M.A., Stack J.A., Pollock B.G., Kupfer D.J. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. J. Am. Med. Assoc. 281:1999;39-45.
48. Reynolds III C.F., Alexopoulos G.S., Katz I.R., Lebowitz B.D. Chronic depression in the elderly: approaches for prevention. Drugs Aging. 18:2001;507-514.
49. Riso L.P., Thase M.E., Howland R.H., Friedman E.S., Simons A.D. A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy. J. Affect. Disord. 43:1997;131-142.
50. Rothman A.J., Salovey P. Shaping perceptions to motivate healthy behavior: The role of message framing. Psychol. Bull. 121:1997;3-19.
51. Sackeim H.A., Haskett R.F., Mulsant B.H., Thase M.E., Mann J.J., Pettinati H.M., Greenberg R.M., Crowe R.R., Cooper T.B., Prudie J. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. J. Am. Med. Assoc. 285:2001;1299-1307.
52. Schoevers R.A., Beekman A.F.T., Deeg D.J.H., Geerlings M.I., Jonker C., Van Tilburg W. Risk factors for depression in later life: results of a prospective community based study (AMSTEL). J. Affect. Disord. 59:2000;127-137.
53. Segal Z.V., Gemar M.C., Williams S. Differential cognitive response to a mood challenge following successful cognitive therapy or pharmacotherapy for unipolar depression. J. Abnorm. Psychol. 108:1999;3-10.
54. Simon G.E. Long-term prognosis of depression in primary care. Bull. WHO. 78:2000;439-445.
55. Simons A.D., Murphy G.E., Levine J.L., Wetzel R.D. Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch. Gen. Psychiatry. 43:1986;43-48.
56. Stein M.B., Fuetch M., Mueller N., Hofler M., Lieb R., Wittchen H. Society anxiety disorder and the risk of depression. Arch. Gen. Psychiatry. 58:2001;251-256.
57. Teasdale J.D. Cognitive vulnerability to persistent depression. Cognition Emotion. 2:1988;247-274.
58. Teasdale J.D., Segal Z.V., Williams J.M.G., Ridgeway V., et al. Prevention of relapse/recurrence in major depression by mindfulness based cognitive therapy. J. Consult. Clin. Psychol. 68:2000;615-623.
59. US Department of Health and Human Services, 2001. Mental Health: Culture, Race and Ethnicity - A Supplement to Mental Health: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services.
60. Weissman M.M., Wolk S., Goldstein R.B., Moreau D., Adams P., Greenwald S., Kiler C.M., Ryan N.D., Dahl R.E., Wickramaratne P. Depressed adolescents grow up. J. Am. Med. Assoc. 281:1999;1707-1713.
61. Wells K.B., Sherbourne C.D., Schoenbaum M., Duan N., Meredith L.S., Unitzer J., Miranda J., Carney M., Rubenstein L.V. Impact of disseminating quality improvement programs for depression in primary care: a randomized controlled trial. J. Am. Med. Assoc. 283:2000;212-220.